A Marine Isolate of Bacillus pumilus Secretes a Pumilacidin Active against Staphylococcus aureus

Mar Drugs. 2018 May 24;16(6):180. doi: 10.3390/md16060180.

Abstract

Producing antimicrobials is a common adaptive behavior shared by many microorganisms, including marine bacteria. We report that SF214, a marine-isolated strain of Bacillus pumilus, produces at least two different molecules with antibacterial activity: a molecule smaller than 3 kDa active against Staphylococcus aureus and a molecule larger than 10 kDa active against Listeria monocytogenes. We focused our attention on the anti-Staphylococcus molecule and found that it was active at a wide range of pH conditions and that its secretion was dependent on the growth phase, medium, and temperature. A mass spectrometry analysis of the size-fractionated supernatant of SF214 identified the small anti-Staphylococcus molecule as a pumilacidin, a nonribosomally synthesized biosurfactant composed of a mixture of cyclic heptapeptides linked to fatty acids of variable length. The analysis of the SF214 genome revealed the presence of a gene cluster similar to the srfA-sfp locus encoding the multimodular, nonribosomal peptide synthases found in other surfactant-producing bacilli. However, the srfA-sfp cluster of SF214 differed from that present in other surfactant-producing strains of B. pumilus by the presence of an insertion element previously found only in strains of B. safensis.

Keywords: B. pumilus; SF214; antimicrobials; lipopeptides; pumilacidin; surfactants; surfactin.

MeSH terms

  • Anti-Bacterial Agents / biosynthesis
  • Anti-Bacterial Agents / isolation & purification
  • Anti-Bacterial Agents / pharmacology*
  • Bacillus pumilus / physiology*
  • Lipopeptides / biosynthesis
  • Lipopeptides / isolation & purification
  • Lipopeptides / metabolism
  • Lipopeptides / pharmacology*
  • Listeria monocytogenes / drug effects
  • Microbial Sensitivity Tests
  • Peptides / isolation & purification
  • Peptides / metabolism
  • Peptides / pharmacology*
  • Staphylococcus aureus / drug effects*
  • Surface-Active Agents / isolation & purification
  • Surface-Active Agents / metabolism
  • Surface-Active Agents / pharmacology

Substances

  • Anti-Bacterial Agents
  • Lipopeptides
  • Peptides
  • Surface-Active Agents
  • pumilacidin